Selenium: metabolism and supplementation in critical illness

Authors

  • Adriana Giraldo Villa Universidad de Antioquia

DOI:

https://doi.org/10.17533/udea.penh.9354

Keywords:

critical patient, supplementation, selenium, antioxidants, oxidative stress, glutathione peroxidase

Abstract

Critical patients are especially vulnerable to deficit of nutrients, because of the hyper metabolic condition, activates some catabolic processes that lead patients to have low plasmatic levels of specific nutrients and increased requirements of them, which, cannot be meet with formulas of standard nutrition. One of the nutrients affected is selenium, indispensable to the formation of selenoproteins that are essential to the function of reducing enzymes such as glutathione peroxidase and is needed to stimulate antioxidant functions.

 

This review summarizes some studies and clinical trials about the use of selenium supplement to increase plasma levels that could improve health parameters in patients with sepsis, burn and trauma. But until now the components in selenium that improve metabolic functions and the mechanisms by which selenium exert immune an antioxidant effects are still far from fully understood. To confirm the scientific basis of the selenium supplementation, there is a need to keep on systematizing newly obtained scientific data on selenium.

|Abstract
= 587 veces | PDF (ESPAÑOL (ESPAÑA))
= 127 veces|

Downloads

Download data is not yet available.

Author Biography

Adriana Giraldo Villa, Universidad de Antioquia

Nutricionista Dietista. Universidad de Antioquia.

References

Manzanares CW. Selenio en los pacientes críticos con respuesta inflamatoria sistémica. Nutr Hosp. 2007;22:295-306.

Ryan HM, Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res. 2005;66:98-102.

Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233-41.

Ducros V, Favier A. Métabolisme du sélénium. EMC-Endocrinologie. 2004;1:19-28.

Angstwurm MWA, Roland G. Practicalities of selenium supplementation in critically ill patients. Clin Nutr Metab Care. 2006;9:233-8.

Stawicki SP, Lyons M, Aloupis M, Sarani B. Current Evidence from Phase III Clinical Trials of selenium supplementation in critically ill patients: why should we bother? Med Chem. 2007;7:693-9.

Vanda L, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9:775-806.

Gil ML, Noguera JA, Martínez P. Determinación de selenio: importancia y medición. En: Asociación Española de analistas farmacéuticos Análisis clínicos. Madrid; 2005. p. 21-30.

Biolo G, Antonione R, De Cicco M. Glutathione metabolism in sepsis. Crit Care Med. 2007;35(9 suppl):S591-S5.

Forceville X. Selenium and the free electron. Selenium a trace to be followed in septic or inflammatory ICU patients?. Intensive Care Med. 2001;27:16-8.

Zazzo J-F. Stress oxydant au cours des états inflammatoires aigus et des états d’agression: implications pour la pratique clinique. Nutr Clin Metab. 2002;16:268-74.

Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med. 1998;26:1536-44.

Coleman NA. Antioxidants in critical care medicine. Environ Toxicol Pharmacol. 2001;10:183-8.

Geoghegan M, McAuley D, Eaton S, Powell-Tuck J. Selenium in critical illness. Crit Care Med. 2006;12:136-41.

Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care. 2002;11:543-51.

Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Care Med. 2002;30:1782-6.

Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro L, et al. The role of oxidative stress in adult critical care. Free Radic Biol Med. 2006;40:398-406.

Zamora JD. Antioxidantes: Micronutrientes la lucha por la salud. Rev Chil Nutr. 2007;34:17-26.

Richards GA. Nutrition and oxidants in the critically ill patient. Clin Pulm Med. 2004;11:183-7.

Bulger EM, Maier RV. Antioxidants in critical illness. Arch Surg. 2001;136:1201-7.

Andresen M, Regueira T, Leighton F. Estrés oxidativo en el paciente crítico. Rev Med Chile 2006;134:649-56.

Berger MM, Shenkin A. Update on clinical micronutrient supplementation studies in the critically ill. Clin Nutr Metab Care. 2006;9:711-6.

Roth E, Manhart N, Wessner B. Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care. 2004;7:161-8.

El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res Fund Mol Mech Mutagen. 2001;475:123-39.

Arthur JR, McKenziey RC, Beckett GJ. Selenium in the immune system. J Nutr. 2003;133:1457S-9S.

Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007;26:41-50.

Angstwurm MW, Schottdorf JM, Schopohl JM, Gaertner RM. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27:1807-13.

Holben DH, Smith AM. The diverse role of selenium whitin selenoproteins: a review. J Am Diet Assoc. 1999;99:836-43.

Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr. 2004;58:391-402.

Abilés J, Lobo G, Pérez de la Cruz A, Rodríguez M, Aguayo E, Cobo MA, et al. Valoración de la ingesta de nutrientes y energía en paciente crítico bajo terapia nutricional enteral. Nutr Hosp. 2005;20:110-4.

Fuhrman MP. Antioxidant supplementation in critical illness: what do we know? Nutrition. 2000;16:470-1.

Office of Dietary Supplements Dietary Supplement [Homepage]. EEUU: National Institutes of Health. [acceso 29 de septiembre de 2007]. Dietary supplement fact sheet: selenium. Disponible en: http://dietarysupplements.info.nih.gov/factsheets/selenium.asp.

Schrauzer GN. Nutritional selenium supplements: Product types, quality, and safety. J Am Coll Nutr. 2001;20:1-4.

Nakamura Y, Feng Q, Kumagai T, Torikai K, Ohigashi H, Osawa T, et al. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. J Biol Chem. 2002;277:2687-94.

Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, et al. Ebselen in acute ischemic stroke: A placebo-controlled, double-blind clinical trial. Stroke. 1998;29:12-7.

Berger MM, Shenkin A. Vitamins and trace elements: Practical aspects of supplementation. Nutrition. 2006;22:952-5.

Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr. 2005;24:172-83.

Kazda A, Brodska H, Valenta J, Vinglerová M, Hendl J, Stach Z, et al. Selenium and its substitution in critically ill patients. Crit Care. 2006;10(Suppl 1):187.

Angstwurm MWA, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118-26.

Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach J-M, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care [revista en Internet]. 2007 Julio [acceso el 15 octubre 2007];11(4):R73. Disponible en: http://ccforum.com/content/11/4/R73.

Porter J, Ivatury R, Azimuddin K, Swami R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am Surg. 1999;65:478-83.

Berger MM, Baines M, Chiolero RL, Wardle CA, Cayeuxa C, Shenkin A. Influence of early trace element and vitamin E supplements on antioxidant status after major trauma: a controlled trial. Nutr Res. 2001;21:41-54.

Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr. 1998;68:365-71.

Kreymann KG, Berger MM, Deutz NEP, Hiesmayr M, Jolliet P, Kazandjiev G, et al. ESPEN Guidelines on enteral nutrition: Intensive care. Clin Nutr. 2006;25:210-23.

Berger MM, Eggimann P, Heyland DK, Chioléro RL, Revelly J-P, Day A, et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care [revista en Internet]. 2006 Noviembre [acceso el 15 octubre 2007]; 10:R153 Disponible en: http://ccforum.com/content/10/6/R153.

Berger MM, Baines M, Raffoul W, Benathan M, Chiolero RL, Reeves C, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007;85:1293-300.

Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31:327-37.

Avenell A, Noble D, Barr J, Engelhardt T. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev. 2006; 2:1-19.

Berger M, Chioléro RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med. 2007;35(suppl 9):S584-S90.

Berger MM, Shenkin A. Selenium in intensive care: Probably not a magic bullet but an important adjuvant therapy. Crit Care Med. 2007;35(1):306-7.

Published

2011-04-24

How to Cite

Giraldo Villa, A. (2011). Selenium: metabolism and supplementation in critical illness. Perspectivas En Nutrición Humana, 9(2), 167–180. https://doi.org/10.17533/udea.penh.9354

Issue

Section

Review articles

Most read articles by the same author(s)